Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Outcomes of overlapping heterogeneous drug-eluting stents versus homogeneous drug-eluting stents for diffuse lesions in small coronary arteries.

Liu SW, Qiao SB, Xu B, Hu FH, Chen J, Yuan JQ, Wu YJ, Yang YJ, Chen JL, Gao RL.

J Interv Cardiol. 2013 Jun;26(3):264-70. doi: 10.1111/j.1540-8183.2013.12023.x. Epub 2013 Mar 14.

PMID:
23488819
2.

Assessment of efficacy and safety of combining "paclitaxel" eluting balloon and "limus" eluting stent in the same lesion.

Basavarajaiah S, Latib A, Hasegawa T, Rezq A, Takagi K, Naganuma T, Kawaguchi M, Figini F, Colombo A.

J Interv Cardiol. 2013 Jun;26(3):259-63. doi: 10.1111/j.1540-8183.2013.12010.x. Epub 2013 Feb 4.

PMID:
23373592
3.

Bare-metal stent versus drug-eluting stent in large coronary arteries: meta-analysis of randomized controlled trials.

Geng DF, Meng Z, Yan HY, Nie RQ, Deng J, Wang JF.

Catheter Cardiovasc Interv. 2013 Jun 1;81(7):1087-94. doi: 10.1002/ccd.24599. Epub 2013 Feb 26.

PMID:
22899538
4.

Long-term clinical outcomes of overlapping heterogeneous drug-eluting stents compared with homogeneous drug-eluting stents.

Her SH, Yoo KD, Park CS, Kim DB, Lee JM, Kim PJ, Kim HY, Chang K, Jeon DS, Chung WS, Seung KB, Kim JH.

Heart. 2011 Sep;97(18):1501-6. doi: 10.1136/hrt.2011.226308. Epub 2011 Jun 30.

PMID:
21719556
5.

Everolimus-eluting stents versus sirolimus- or paclitaxel-eluting stents: two-year results from the Guthrie Health Off-Label Stent (GHOST) registry.

Harjai KJ, Kondareddy S, Pinkosky B, Harjai N, Orshaw P, Boura J.

J Interv Cardiol. 2013 Apr;26(2):153-62. doi: 10.1111/j.1540-8183.2013.12016.x. Epub 2013 Jan 31.

PMID:
23363439
6.

Treatment of coronary bifurcation lesions with drug-eluting stents: insights from the first phase of the prospective multicenter german drug-eluting stent registry.

Abdel-Wahab M, Nienaber CA, Mostafa AE, Ferenc M, Silber S, Sabin G, Tebbe U, Akin I, Hochadel M, Senges J, Kuck KH, Richardt G; German Drug-Eluting Stent (DES.DE) Registry.

J Interv Cardiol. 2012 Aug;25(4):344-52. doi: 10.1111/j.1540-8183.2011.00718.x. Epub 2012 Mar 12.

PMID:
22409587
7.

Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.

Bangalore S, Kumar S, Fusaro M, Amoroso N, Attubato MJ, Feit F, Bhatt DL, Slater J.

Circulation. 2012 Jun 12;125(23):2873-91. doi: 10.1161/CIRCULATIONAHA.112.097014. Epub 2012 May 14.

8.

Safety and efficacy of everolimus-eluting stents versus paclitaxel-eluting stents in a diabetic population.

Laynez A, Sardi G, Hauville C, Barbash IM, Pakala R, Torguson R, Xue Z, Satler LF, Pichard AD, Waksman R.

Catheter Cardiovasc Interv. 2013 Apr;81(5):759-65. doi: 10.1002/ccd.24438. Epub 2012 Apr 23.

PMID:
22488756
9.

Long-term clinical outcomes of the one-stent technique versus the two-stent technique for non-left main true coronary bifurcation disease in the era of drug-eluting stents.

Koh YS, Kim PJ, Chang K, Park HJ, Jeong MH, Kim HS, Jang Y, Gwon HC, Park SJ, Seung KB.

J Interv Cardiol. 2013 Jun;26(3):245-53. doi: 10.1111/joic.12025. Epub 2013 Mar 11.

PMID:
23480867
10.

Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.

Chen SL, Ye F, Zhang JJ, Zou JJ, Qian XS, Li F, Yang S, Ge Z, Shan SJ, Li XB, Xu T, Kan J, Lin L, Han YL.

Cardiovasc Ther. 2013 Aug;31(4):193-200. doi: 10.1111/j.1755-5922.2012.00319.x.

PMID:
22954234
11.

Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry.

Yan BP, Ajani AE, New G, Duffy SJ, Farouque O, Shaw J, Sebastian M, Lew R, Brennan A, Andrianopoulos N, Reid C, Clark DJ; Melbourne Interventional Group Investigators.

Int J Cardiol. 2008 Nov 28;130(3):374-9. doi: 10.1016/j.ijcard.2008.06.046. Epub 2008 Aug 15.

PMID:
18706719
12.
13.

Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions trial.

Brener SJ, Kereiakes DJ, Simonton CA, Rizvi A, Newman W, Mastali K, Wang JC, Caputo R, Smith RS Jr, Ying SW, Cutlip DE, Stone GW.

Am Heart J. 2013 Dec;166(6):1035-42. doi: 10.1016/j.ahj.2013.08.030. Epub 2013 Oct 31.

PMID:
24268218
14.

Percutaneous coronary intervention with second-generation paclitaxel-eluting stents versus everolimus-eluting stents in United States contemporary practice (REWARDS TLX Trial).

Waksman R, Ghali M, Goodroe R, Ryan T, Turco M, Ring M, McGarry T, Dobies D, Shammas N, Steinberg DH, Swymelar S, Kaneshige K, Torguson R.

Am J Cardiol. 2012 Oct 15;110(8):1119-24. doi: 10.1016/j.amjcard.2012.05.050. Epub 2012 Jul 3.

PMID:
22762711
15.

Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization.

Das P, Moliterno DJ, Charnigo R, Mukherjee D, Steinhubl SR, Sneed JD, Booth DC, Ziada KM.

J Invasive Cardiol. 2006 Sep;18(9):405-8.

PMID:
16954577
16.

Six-year clinical outcomes of first-generation drug-eluting stents: a propensity-matched analysis.

Tarantini G, Barioli A, Facchin M, Frigo AC, Napodano M, Buja P, D'Amico G, Iliceto S, Isabella G.

Coron Artery Dis. 2013 Aug;24(5):440-8. doi: 10.1097/MCA.0b013e328362b2ab.

PMID:
23695366
17.

Primary percutaneous coronary intervention for acute myocardial infarction: long-term outcome after bare metal and drug-eluting stent implantation.

Kukreja N, Onuma Y, Garcia-Garcia H, Daemen J, van Domburg R, Serruys PW.

Circ Cardiovasc Interv. 2008 Oct;1(2):103-10. doi: 10.1161/CIRCINTERVENTIONS.108.787762. Epub 2008 Sep 3.

18.

Duration of dual antiplatelet therapy after implantation of the first-generation and second-generation drug-eluting stents.

Yu X, Chen F, He J, Gao Y, Wu C, Luo Y, Zhang X, Zhang Y, Ren X, Lv S.

Coron Artery Dis. 2013 May;24(3):217-23. doi: 10.1097/MCA.0b013e32835c8f74.

PMID:
23425771
19.

Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation.

Jeong YH, Hong MK, Lee CW, Park DW, Kim YH, Kim JJ, Park SW, Park SJ.

Int J Cardiol. 2008 Mar 28;125(1):36-40. Epub 2007 May 22.

PMID:
17521753
20.

Clinical and angiographic outcomes after placement of multiple overlapping drug-eluting stents in diffuse coronary lesions.

Lee CW, Park KH, Kim YH, Hong MK, Kim JJ, Park SW, Park SJ.

Am J Cardiol. 2006 Oct 1;98(7):918-22. Epub 2006 Aug 8.

PMID:
16996874

Supplemental Content

Support Center